Health care analysis on myocardial revascularization in patients with chronic coronary heart disease (CHD)

Health care analysis on myocardial revascularization in patients with chronic coronary heart disease (CHD) - REVASK

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022175

Enrollment

1000

Registered

2020-08-27

Start date

2021-09-09

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic CHD in the form of a 2- or 3-vessel or main-vessel disease I25

Interventions

Group 1: non-interventional observational study, patients are surveyed via written questionnaire at two time points of data collection (T0: directly before the procedure, T1: 6 months after the proced

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients (a) with chronic coronary heart disease and (b) 2- or 3-vessel or main-vessel disease (c) who are being treated at one of the recruitment sites (d) with a promptly planned intervention for myocardial revascularization

Exclusion criteria

Exclusion criteria: missing informed consent

Design outcomes

Primary

Measure	Time frame
Guidelines-compliant therapy in patients with chronic CHD (2- or 3-vessel or main vessel disease) according to NVL cKHK	—

Secondary

Measure	Time frame
Frequency and quality of heart teams; extent of patient participation in the decision making process; importance of clinical parameters in the decision-making process (e.g. syntax scores, iFR, FFR)	—

Countries

Germany

Contacts

Public ContactEva Maria;Peter Bitzer;Ihle

Pädagogische Hochschule Freiburg / Public Health & Health Education;Universitätsklinikum Köln / PMV forschungsgruppe

evamaria.bitzer@ph-freiburg.de;peter.ihle@uk-koeln.de0761 682-142;0221/478-85532

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026